Appropriateness of lyme disease serologic testing

Annals of Family Medicine

Volumn 2, Issue 4, 2004, Pages 341-344

  Ramsey, Alan H ^a,b   Belongia, Edward A ^c   Chyou, Po Huang ^c   Davis, Jeffrey P ^a  

^a WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c MARSHFIELD CLINIC   (United States)

Author keywords

Borrelia burgdorferi; Lyme disease; Serologic test utilization

Indexed keywords

ARTICLE; EDUCATION; ENZYME IMMUNOASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; LYME DISEASE; MEDICAL PRACTICE; PATIENT REFERRAL; SEROLOGY;

ANIMALS; BITES AND STINGS; CROSS-SECTIONAL STUDIES; GUIDELINE ADHERENCE; HUMANS; LYME DISEASE; PATIENT SELECTION; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; RISK FACTORS; SEROLOGIC TESTS; TICKS; WISCONSIN;

EID: 4243088182     PISSN: 15441709     EISSN: None     Source Type: Journal    
DOI: 10.1370/afm.117     Document Type: Article

References (16)

1. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt G, Davis JP. Lyme disease - a tick-borne spirochetosis? Science. 1982;216:1317-1319.
2. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:733-740.
3. Steere AC. Lyme Disease. N Engl J Med. 2001;345:115-125.
4. Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:1009-1023.
5. Steere AC, Taylor E, McHugh GL, Logigian EC. The overdiagnosis of Lyme disease. JAMA. 1993;269:1812-1816.
6. Ley C, Le C, Olshen E, Reingold AL. The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA. 1994;271:460-463.
7. Magri JM, Johnson MT, Herring TA, Greenblatt JF. Lyme disease knowledge, beliefs and practices of New Hampshire primary care physicians. J Am Board Fam Pract. 2002;15:277-284,
8. Bunikis J, Barbour AG. Laboratory testing for suspected Lyme disease. Med Clin North Am. 2002;86:311-340.
9. Seltzer EG, Shapiro ED. Misdiagnosis of Lyme disease: when not to order serologic tests. Pediatr Infect Dis J. 1996;15:762-763.
10. American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:1106-1108.
11. Reid MC, Schoen RT, Evans JT, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med. 1998;128:354-362.
12. Sigal LH. The Lyme disease controversy: social and financial costs of misdiagnosis and mismanagement. Arch Intern Med. 1996;156:1493-1500.
13. Qureshi MZ, New D, Zulquami MJ, Machman S. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J. 2002;21:12-14.
14. Ettestad PJ, Campbell GL, Welbel SF, et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis. 1995;171:360-361.
15. Centers for Disease Control and Prevention. Addressing Emerging Infectious Diseases: A Strategy For the 21st Century. Atlanta: U.S. Department of Human Services, Public Health Service; 1998.
16. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001;345:79-84.